Page 90 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• P569 Gilteritinib and quizartinib in relapsed/refractory (R/R) acute myeloblastic leu- kemia (AML) with FLT3 mutations: a real-life effectiveness and safety study.
27th Congress of the European Hematology Association. EHA2022 Hybrid Viena (Jun 9-17). Quintela D, Morgades M, Serrano A, Cervera M, Balerdi A, Díaz-Beyá M, Arnán M, Garrido A, Coll R, Tormo M, López-Marín J, Merchán B, García S, Casado M, Sampol A, Esteve J, Martínez-Cuadrón D, Sierra J, Sanz MA, Ribera JM, Montesinos P, Vives S .
Grupo de trabajo coautor: LAM .
• PB1845 Acute myeloid leukemia in the elderly: a multicenter experience in Colom- bia, on behalf of ACHO’S RENEHOC investigators.
27th Congress of the European Hematology Association. EHA2022 Hybrid Viena (Jun 9-17). Sossa-Melo C, Abello V, Solano M, Peña A, Rosales M, Quintero G, Mantilla W, Salazar L, Idrobo H, Reyes J, Gaviria L, Bermúdez C, Gómez R, Correa M, Herrera J, Guerrero P, Gálvez K, Martínez-Cuadrón D, Sanz MA, Montesinos P .
Grupo de trabajo coautor: LAM .
• Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents. a Big Data Analysis from the Harmony Collaboration.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Sobas MA, Villaverde Ramiro A, Hernández Sánchez A, Martínez Elicegui J, González T, Azi- beiro Melchor R, Abáigar M, Tur L, Dall’Olio D, Sträng E, Tettero JM, Gastone C, Benner A, Döh- ner K, Thiede C, Turki AT, Metzeler KH, Haferlach T, Damm F, Ayala R, Martínez-López J, Mills KI, Sierra J, Lehmann S, Della Porta MG, Mayer J, Reinhardt D, Villoria Medina R, Schulze-Rath R, Barbus M, Hernández-Rivas JM, Patrick Huntly BJ, Ossenkoppele G, Dohner H, Bullinger L . Grupo de trabajo coautor: LAM .
• Prognostic Impact of NPM1 and FLT3-ITD Mutations in Patients Treated with Non-In- tensive Regimens: A Pethema Registry Study.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Uriel Suárez E, Alonso JM, Boluda B, Lavilla E, Tormo M, Botella C, Vives S, Rodríguez C, Serrano J, Sayas MJ, Martínez Sánchez P, Ramos F, Bernal del Castillo T, Algarra L, Bergua Burgués JM, Pérez-Simón J, Herrera P, Barrios-García M, Noriega-Concepción V, Raposo-Puglia JA, Ayala R, Barragán E, Martínez-Cuadrón D, Montesinos P .
Grupo de trabajo coautor: LAM .
90